Piotr Pieńkowski

Piotr Pieńkowski

Auto-generated profile, based on publicly available information

Piotr Pieńkowski

Department of Head and Neck Surgery, Poznan University of Medical Sciences, 61-701 Poznan, Poland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Radiology and Oncology
Verified
Journal Article
Open access
PDF file
EMEwa Majchrzak
Ewa Majchrzak
BSBartosz Szybiak
Bartosz Szybiak
AWAnna Wegner
Anna Wegner
PPPiotr Pienkowski
Piotr Pienkowski
JPJakub Pazdrowski
Jakub Pazdrowski
Wojciech GolusiñskiWojciech Golusiñski
Wojciech Golusiñski
Background. Head and neck squamous cell carcinoma (HNSCC) is a disease of middle-aged to elderly adults. However, an increased incidence of HNSCC in young people under 45 years of age has been reported recently. In the present review, we focused on the epidemiology and aetiology of HNSCC in adults under 45 years of age.Methods. We reviewed literature related to HNSCC in adult patients less than 45 years of age and discussed current treatment options and prognosis.Results. HNSCC in young adults is associated with a higher incidence rate in nonsmokers, lower female-to-male ratio, a higher percentage of oral cavity and oropharynx tumours, and fewer second primary tumours. However, aside from traditional risk factors of tobacco and alcohol exposure, the causes of these cancers in young adults remain unclear. Agents that might contribute to risk include infection with high-risk human papillomavirus subtypes as well as genetic factors or immunodeficiency status. The expected increase in incidence and mortality of the young with HNSCC may become a major public health concern if current trends persist, particularly lifestyle habits that may contribute to this disease.Conclusions. Given the younger age and potential long-term adverse sequelae of traditional HNSCC treatments, young adults should be treated on a case-by-case basis and post-therapy quality of life must be considered in any treatment-decision making process.

12 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MSMateusz Szewczyk
Mateusz Szewczyk
JPJakub Pazdrowski
Jakub Pazdrowski
PPPiotr Pieńkowski
Piotr Pieńkowski
BWBartosz Wojtera
Bartosz Wojtera
BWBarbara Więckowska
Barbara Więckowska
Wojciech GolusiñskiWojciech Golusiñski
Wojciech Golusiñski
In patients with oral cancer, the risk factors for local, regional, and distant recurrence according to margin status have not been well established. We aimed to determine the risk factors for recurrence by margin status and to identify a margin cut-off point for improved survival in patients with close margins. We retrospectively reviewed adult patients treated at our centre from 2009 to 2021 for primary oral cancer. Margins were classified as positive (5 mm). Univariate and multivariate analyses were performed. A total of 326 patients (210 men) were included. The mean age was 59.1 years. Margin status was close (n = 168, 51.5%), clear (n = 83, 25.4%), or positive (n = 75, 23.0%). In the univariate analysis, positive surgical margins (HR = 7.53) had the greatest impact on distant failure. Positive surgical margins—without nodal involvement—had the greatest impact on the risk of distant failure. In the close margin group, the optimal cut-off for disease-free survival (AUC = 0.58) and overall survival (AUC = 0.63) was a deep margin > 3 mm, with survival outcomes that were comparable to the clear margin group. These finding suggest that margins < 5 mm may be sufficient in certain well-defined cases. Prospective studies are warranted to confirm these findings.

1 July 2018 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
MSMateusz Szewczyk
Mateusz Szewczyk
PGPaweł Golusiński
Paweł Golusiński
JPJakub Pazdrowski
Jakub Pazdrowski
PPPiotr Pieńkowski
Piotr Pieńkowski
SMSławomir Marszałek
Sławomir Marszałek
Wojciech GolusiñskiWojciech Golusiñski
Wojciech Golusiñski
The purpose of the study was to publish our experience of salivary gland cancer treatment with large number of patients treated at a single institution. Salivary gland cancers are rare tumors of the head and neck representing about 5% of cancers in that region and about 0.5% of all malignancies. Due to the rarity of the disease, most of the studies regarding treatment outcome consist of low number of patients, thus making it difficult to draw conclusions. 115 patients with primary salivary gland cancer were included in a retrospective study. The subsites of tumor were the parotid gland (58% patients), submandibular gland (19%) and minor salivary glands (23%). All patients underwent primary surgical resection. The following were collected: age, stage of the disease, T status, N status, grade of tumor, perineurial invasion, lymphovascular invasion, extracapsular spread, final histological margin status and postoperative treatment. Details of local, regional or distant recurrence, disease free survival and overall survival were included. The majority (65%) of patients presented in early stage, T1 and T2 tumors. 81% of patients were N0. Free surgical margins were achieved in 18% of patients, close in 28% patients and positive surgical margins in 54% (62) patients. Factors that significantly increased the risk of recurrence: T stage (p = 0.0006); N-positive status (p < 0.0001); advanced stage of the disease (p < 0.0001); high grade of tumor (p = 0.0007); PNI (p = 0.0061); LVI (p = 0.0022); ECS (p = 0.0136); positive surgical margins (p = 0.0022). On multivariate analysis, high grade of tumor and positive surgical margins remained significant independent adverse factors for recurrence formation. This report shows a single institution results of oncological treatment in patients with malignant salivary gland tumors, where positive surgical margins strongly correlate with patients' worse outcome. Whether to extend the procedure, which very often requires sacrificing the nerve is still a question of debate.

25 July 2013
Verified
Journal Article
Closed access
PDF file
PGPaweł Golusiński
Paweł Golusiński
ŁŁŁukasz Łuczewski
Łukasz Łuczewski
JPJakub Pazdrowski
Jakub Pazdrowski
TSTomasz Synowiec
Tomasz Synowiec
PPPiotr Pieńkowski
Piotr Pieńkowski
Wojciech GolusiñskiWojciech Golusiñski
Wojciech Golusiñski

17 April 2014 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
AWAgnieszka Wiertel-Krawczuk
Agnieszka Wiertel-Krawczuk
Juliusz HuberJuliusz Huber
Juliusz Huber
MWMagdalena Wojtysiak
Magdalena Wojtysiak
Wojciech GolusiñskiWojciech Golusiñski
Wojciech Golusiñski
PPPiotr Pieńkowski
Piotr Pieńkowski
PGPaweł Golusiński
Paweł Golusiński
Parotid gland tumor surgery sometimes leads to facial nerve paralysis. Malignant more than benign tumors determine nerve function preoperatively, while postoperative observations based on clinical, histological and neurophysiological studies have not been reported in detail. The aims of this pilot study were evaluation and correlations of histological properties of tumor (its size and location) and clinical and neurophysiological assessment of facial nerve function pre- and post-operatively (1 and 6 months). Comparative studies included 17 patients with benign (n = 13) and malignant (n = 4) tumors. Clinical assessment was based on House–Brackmann scale (H–B), neurophysiological diagnostics included facial electroneurography [ENG, compound muscle action potential (CMAP)], mimetic muscle electromyography (EMG) and blink-reflex examinations (BR). Mainly grade I of H–B was recorded both pre- (n = 13) and post-operatively (n = 12) in patients with small (1.5–2.4 cm) benign tumors located in superficial lobes. Patients with medium size (2.5–3.4 cm) malignant tumors in both lobes were scored at grade I (n = 2) and III (n = 2) pre- and mainly VI (n = 4) post-operatively. CMAP amplitudes after stimulation of mandibular marginal branch were reduced at about 25 % in patients with benign tumors after surgery. In the cases of malignant tumors CMAPs were not recorded following stimulation of any branch. A similar trend was found for BR results. H–B and ENG results revealed positive correlations between the type of tumor and surgery with facial nerve function. Neurophysiological studies detected clinically silent facial nerve neuropathy of mandibular marginal branch in postoperative period. Needle EMG, ENG and BR examinations allow for the evaluation of face muscles reinnervation and facial nerve regeneration.

1 September 2010 in Otolaryngologia Polska
Verified
Journal Article
Closed access
PPPiotr Pieńkowski
Piotr Pieńkowski
WGWojciech Golusiński
Wojciech Golusiński
AWAgnieszka Wiertel-Krawczuk
Agnieszka Wiertel-Krawczuk
JHJuliusz Huber
Juliusz Huber
The route of the facial nerve in its extracranial part determines the technique of parotid gland surgery. Permanent facial nerve paralysis after parotidectomy is not rare. It is the most devastating complication for the patient and surgeon. Facial nerve monitoring by observing or palpating the face during the surgery is a long-standing practice. Using an EMG device is a standard procedure at present. Evaluation of the effectiveness of intraoperative facial nerve monitoring for parotid gland surgery. Fifty three patients operated on due to parotid gland tumour in the Head and Neck Surgery and Laryngological Oncology Department of the Greater Poland Cancer Center in 2007-2008. All patients had been provided with EMG and ENG examinations of the facial nerve before the surgery and continuous facial nerve monitoring during the operation. Facial nerve function after surgery was assessed according to the House-Brackmann grading system. Six (12%) patients presented facial nerve dysfunction after surgery. Three (6%) patients had temporary paralysis grade III H-B with complete recovery in 6 weeks. Three (6%) patients with deep lobe tumour had grade V H-B with complete recovery in one patient after 3 months, and two (4%) patients had grade III H-B after one year since the surgery. Intraoperative facial nerve monitoring should be a standard procedure during parotid gland surgery in most clinical situations.